Active Biotech

After digging through discards, biotech startup is making a $45M bet it can fix a failed cancer therapy
Endpoints
Thu, 02/20/20 - 10:39 am
Active Biotech
naptumomab
renal cell carcinoma
NeoTX
Multiple Sclerosis Update: Biogen, Sanofi, Active, Adamas and Novartis
BioSpace
Sun, 02/9/20 - 04:01 pm
MS
multiple sclerosis
Biogen
Sanofi
Active Biotech
Mylan
Novartis
Adamas
Active Biotech is back, with one last bid for the failed MS drug Teva discarded
Endpoints
Wed, 02/5/20 - 10:11 am
Teva Pharmaceutical
Active Biotech
laquinimod
MS
multiple sclerosis
Teva’s one-time blockbuster-to-be — and now recurring embarrassment — laquinimod fails yet again, this time for Huntington’s
Endpoints
Tue, 07/31/18 - 12:25 pm
Teva Pharmaceutical
Active Biotech
Huntington's disease
clinical trials
laquinimod
Troubled Teva’s successor to Copaxone just failed a big PhIII test for multiple sclerosis
Endpoints
Sun, 05/7/17 - 11:11 am
Teva Pharmaceutical
Copaxone
MS
multiple sclerosis
laquinimod
Active Biotech
Active Biotech axes 84% of staff in retreat from R&D
Fierce Biotech
Thu, 06/4/15 - 11:56 am
layoffs
Active Biotech
R&D
Teva, Active Biotech to continue development of Nerventra
The Fly on the Wall
Fri, 05/23/14 - 07:00 am
Teva Pharmaceuticals
Nerventra
Active Biotech
MS
multiple sclerosis
Teva decides not to proceed to randomization stage of trial for laquinimod
Yahoo/Fly on the Wall
Wed, 02/19/14 - 08:40 am
laquinimod
clinical trials
Teva Pharmaceuticals
Relapsing Remitting Multiple Sclerosis
RRMS
MS
Active Biotech
Teva’s Laquinimod MS Pill Fails to Win EU Agency Backing
Bloomberg
Sat, 01/25/14 - 11:39 am
Teva Pharmaceuticals
MS
multiple sclerosis
Active Biotech
laquinimod
Teva Pharma (TEVA) + Active Biotech (ACTI) = Firmly Committed to NERVENTRA Program
Street Insider
Sat, 01/25/14 - 11:34 am
Teva Pharmaceuticals
Active Biotech
Nerventra
laquinimod
MS
multiple sclerosis
Teva/Active Biotech MS pill accepted for review in Europe
Pharma Times, UK
Tue, 07/17/12 - 11:43 am
Teva Pharmaceuticals
Active Biotech
MS
multiple sclerosis
Europe
Active Biotech shares slump after Phase III result
Marketwatch
Mon, 08/1/11 - 10:22 am
Active Biotech
laquinimod
Teva Pharmaceuticals
MS
multiple sclerosis
Teva, Active extend pact on oral MS therapy
Marketwatch
Mon, 02/8/10 - 11:37 am
Teva Pharmaceuticals
Active Biotech
partnerships
MS
multiple sclerosis
Teva Pharmaceutical Industries, Active Biotech drug candidate gets expedited review by FDA
Yahoo/AP
Fri, 02/13/09 - 07:21 am
Teva Pharmaceuticals
FDA
Active Biotech
laquinimod
MS
multiple sclerosis